Thursday, June 27, 2019

How does depression associated with PCOS


Polycystic ovary syndrome or also known as PCOS is one of the most common hormone disorders affecting women, with a prevalence of 5–10% in women of reproductive age. Polycystic ovarian syndrome symptomsand treatment are very common and the reason for it is androgen excess in women and the most common cause of ovulatory failure we most commonly seen. Moreover, the androgen excess presents as hirsutism and acne, whereas an ovulation presents as subfertility and menstrual irregularity takes place. In addition, PCOS is also associated with obesity. It is therefore perhaps not surprising that women with PCOS experience mood dysfunction and psychiatric problems to a greater degree than women without PCOS in their life as we see on a daily basis. We have also found out that anxiety and depression are higher in PCOS than any other healthy women. Most of the time we have found that in depression and anxiety in PCOS is also an important issue that should be treated.

We suggested that most mood problems in PCOS are caused by the distress associated with the symptoms often seen in PCOS. In general, we find that obesity is related to depression, both in healthy women and in PCOS. In a review of the quality of life literature on polycystic ovarian syndrome, depression found that weight problems had the greatest negative impact on women. However, not all studies of obesity in PCOS have found this find that depression is higher in women with PCOS even after controlling for BMI in them.

Per women vary in how much their mood is affected by the various PCOS symptoms. We suggest that PCOS symptoms that affect appearance are more likely to cause distress in younger women than older women. Because PCOS involves so many potentially distressing symptoms, it is difficult to identify the main cause of distress or the relative contribution of causal factors. We have noticed that physical symptoms of PCOS are largely the result of elevated testosterone; for example, hirsutism is caused by elevated androgen levels. Hirsutism is also associated with distress in women with PCOS. Thus, it is tempting to view distress in PCOS as mainly an indirect effect of testosterone and the cure for distress, therefore, to lower testosterone levels.

Two drugs widely used to treat the symptoms of PCOS, metformin and the oral contraceptive co-cyprindiol, differ in their action; metformin acts primarily to increase insulin sensitivity, whereas co-cyprindiol is composed of estrogen and anti-androgen. Some authors use the umbrella term ‘anti-androgens’ to describe these and other medications of this kind used to treat PCOS. In women with PCOS found that co-cyprindiol was more effective than metformin in treating acne, whereas hirsutism responded better to metformin than co-cyprindiol.

We suggest that the drugs commonly used to reduce symptoms of PCOS may also reduce the distress associated with these symptoms. In support of this suggestion found that women with PCOS taking oral contraceptives were significantly less depressed than those with PCOS not taking oral contraceptives. We have found that rates of depression were slightly higher in women with PCOS taking anti-androgens (71%) than women with PCOS not taking anti-androgens (67%). Depression rates were lower in controls and showed the opposite pattern; 30% taking anti-androgens and 37% not taking anti-androgens showed some of the sign of depression. Thus there is, at present, uncertainty regarding the benefits of medications on mood in PCOS anddepression and anxiety.

The primary objective of the present paper is to assess the degree to which women with PCOS score differently to women without PCOS on measures of anxiety and depression. The secondary objective is to determine whether there is an impact of BMI and PCOS medication use on anxiety and depression scores rate. All between-groups designs were considered.

No comments:

Post a Comment